Ask Warren

BioSmart

038460 · KOSDAQ · ₩038460 · 바이오스마트

₩2,460▲ ₩40 (1.65%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −14.29%
Market cap
₩62B
Enterprise value
₩104B
P/E
4.6×
P/B
0.4×
Dividend yield
0.0%
ROE
9.0%
Net margin
2.4%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−64.5% from the high

₩2,305Today: ₩2,405 – ₩2,485₩6,930

Returns

  • 1W−7.5%
  • 1M−11.8%
  • 3M−6.1%
  • 6M−42.7%
  • YTD−36.9%
  • 1Y−14.3%
Volume today
41,605
0.4× the 20-day average
Traded today
₩102M
Listed shares
25,274,542
EPS (12 months)
₩534
Earnings yield 21.7%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

32Quiet
  • BuzzQuietBuzz 32 of 100 (50 is a normal day for this stock).
  • MomentumWeak-13.7% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

BioSmart stock overview

BioSmart (바이오스마트, KRX: 038460) is listed on KOSDAQ, in the Electronic components sector. The company operates through several businesses: smart card manufacturing (including credit cards, IC cards, and access passes), pharmaceuticals (prescription and over-the-counter drugs), liquor payment services (liquor payment agency, payment terminals, and an ERP system), heavy electrical and copper products (power infrastructure and automotive materials, motor stator manufacturing and repair), and book publishing (books, a design magazine, and a book club). Its shares closed at ₩2,460 on Oct 27, 2026, up 1.65% on the day, giving it a market value of ₩62B.

Key facts

Market cap
₩62B
Sector
Electronic components
Latest price change
+1.65%
As of
Oct 27, 2026
Main business
The company operates through several businesses: smart card manufacturing (including credit cards, IC cards, and access passes), pharmaceuticals (prescription and over-the-counter drugs), liquor payment services (liquor payment agency, payment terminals, and an ERP system), heavy electrical and copper products (power infrastructure and automotive materials, motor stator manufacturing and repair), and book publishing (books, a design magazine, and a book club).

Quick answers about BioSmart

What does BioSmart do?
The company operates through several businesses: smart card manufacturing (including credit cards, IC cards, and access passes), pharmaceuticals (prescription and over-the-counter drugs), liquor payment services (liquor payment agency, payment terminals, and an ERP system), heavy electrical and copper products (power infrastructure and automotive materials, motor stator manufacturing and repair), and book publishing (books, a design magazine, and a book club). It pursues diversified growth across these unrelated industries to manage risks in mature markets, with operations centered in South Korea.
What is the market cap of BioSmart?
The market capitalisation of BioSmart was ₩62B at the close on Oct 27, 2026.
Who are the largest shareholders of BioSmart?
According to the latest official filings, the largest reported holders are Park Hye-rin (26.55%, as of Aug 12, 2026); Yun Ho-gwon (4.27%, as of Sep 9, 2026); Korea Securities Finance (4.07%, as of Jul 9, 2026).
When is the next earnings report from BioSmart?
Korean companies rarely announce results dates in advance. Based on when BioSmart filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company operates through several businesses: smart card manufacturing (including credit cards, IC cards, and access passes), pharmaceuticals (prescription and over-the-counter drugs), liquor payment services (liquor payment agency, payment terminals, and an ERP system), heavy electrical and copper products (power infrastructure and automotive materials, motor stator manufacturing and repair), and book publishing (books, a design magazine, and a book club). It pursues diversified growth across these unrelated industries to manage risks in mature markets, with operations centered in South Korea.

Written by AI from the company's latest annual report.

Korean name
바이오스마트
Sector
Electronic components
Themes
Biotech (new drugs)
CEO
윤호권
Founded
Dec 1985
Listed
Jun 2000
Listed shares
25,274,542
Fiscal year ends
Month 12
Website
www.bio-smart.com

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: BioSmart / 바이오스마트 / 038460 / KRX:038460

Source: KRX statistical information